Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Contrast Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions

NCT04324294 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT04324294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04324294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Contrast Enhanced Endoscopic Ultrasound for Evaluation of Pancreas Lesions
Lead sponsor
Cedars-Sinai Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
February 26, 2020
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer, pancreas cyst, pancreatitis